- Report
- September 2025
- 50 Pages
United States
From €4436EUR$4,995USD£3,875GBP
- Report
- August 2024
- 150 Pages
Global
From €2664EUR$3,000USD£2,327GBP
€3330EUR$3,750USD£2,909GBP
- Report
- August 2024
- 150 Pages
Global
From €2664EUR$3,000USD£2,327GBP
€3330EUR$3,750USD£2,909GBP
- Report
- July 2024
- 150 Pages
Global
From €2664EUR$3,000USD£2,327GBP
€3330EUR$3,750USD£2,909GBP
- Report
- May 2024
- 200 Pages
Global
From €3686EUR$4,150USD£3,220GBP
- Report
- May 2024
- 200 Pages
Global
From €3686EUR$4,150USD£3,220GBP
- Report
- October 2023
- 145 Pages
Global
From €2797EUR$3,150USD£2,444GBP
- Report
- November 2023
- 149 Pages
Global
From €3952EUR$4,450USD£3,452GBP
- Report
- April 2023
- 75 Pages
South Africa
From €4218EUR$4,750USD£3,685GBP
- Report
- April 2023
- 111 Pages
Global
From €4218EUR$4,750USD£3,685GBP
- Report
- October 2024
- 200 Pages
Global
From €4395EUR$4,949USD£3,840GBP
- Report
- July 2024
- 158 Pages
Global
From €3208EUR$3,613USD£2,803GBP
€3774EUR$4,250USD£3,297GBP
- Report
- September 2025
- 45 Pages
Canada
From €4436EUR$4,995USD£3,875GBP
- Report
- September 2025
- 37 Pages
Australia
From €4436EUR$4,995USD£3,875GBP
- Report
- September 2025
- 38 Pages
India
From €4436EUR$4,995USD£3,875GBP
- Report
- September 2025
- 37 Pages
Germany
From €4436EUR$4,995USD£3,875GBP
- Report
- September 2025
- 47 Pages
France
From €4436EUR$4,995USD£3,875GBP
- Report
- August 2024
- 96 Pages
North America
From €5324EUR$5,995USD£4,651GBP
- Report
- August 2024
- 135 Pages
Europe
From €5324EUR$5,995USD£4,651GBP
- Report
- August 2024
- 126 Pages
Asia Pacific
From €5324EUR$5,995USD£4,651GBP

The Circulatory Support Device market is a subset of the Cardiovascular Devices market, which includes a range of products used to diagnose and treat cardiovascular diseases. Circulatory Support Devices are used to provide temporary or permanent support to the heart and/or lungs, and can be used to treat a variety of conditions, including heart failure, pulmonary hypertension, and cardiogenic shock. These devices are typically implanted, and can include ventricular assist devices, extracorporeal membrane oxygenation (ECMO) systems, and total artificial hearts.
Circulatory Support Devices are used in both acute and chronic settings, and are typically used in conjunction with other treatments, such as medications and lifestyle changes. The market is expected to grow in the coming years, driven by an aging population and increasing prevalence of cardiovascular diseases.
Notable companies in the Circulatory Support Device market include Abiomed, Medtronic, Berlin Heart, SynCardia Systems, and HeartWare International. Show Less Read more